STOCK TITAN

Inspira Technologies Oxy Bhn Ltd reported $289K in revenue and a $13.2M net loss for fiscal 2025. See the full IINN financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

One of Israel’s 3 Largest Defense Companies Begins Immediate Deployment of QTREX Quantum’s AME Technology

(Positive)
Tags

QTREX Quantum (QTEX) reported that one of Israel's three largest defense companies, described as a leading global aerospace and defense organization, has begun deploying QTREX's Additively Manufactured Electronics (AME) technology under a joint development program.

The first QTREX AME system is being installed at the partner’s facilities. The agreement includes exclusivity provisions and outlines a potential phased commercial pathway for broader AME system rollouts, with aggregate revenue for QTREX described as being in the tens of millions of dollars. The partner’s identity is not disclosed due to confidentiality obligations.

The joint program will adapt QTREX’s proprietary AME platform to the partner’s engineering, performance and reliability requirements through customized R&D, advanced materials and process optimization. Initial revenue is expected from immediate system deployment and recurring consumables, while later phases, subject to definitive agreements, contemplate procurement of tailored AME systems.

Loading...
Loading translation...

Positive

  • Major defense partner begins deployment with first QTREX AME system now installing at the partner’s facilities
  • Exclusivity provisions in the agreement highlight the partner’s stated strategic importance of QTREX’s AME technology
  • Phased commercial pathway envisions aggregate QTREX revenue in the tens of millions of dollars from broader AME rollouts
  • Recurring revenue stream described from consumables associated with the immediate AME system deployment

Negative

  • Future phases contingent on negotiation and execution of definitive agreements before additional AME system procurements occur
  • Partner remains undisclosed due to confidentiality, limiting external validation of the counterparty and its potential impact
  • No specific timelines or financial commitments disclosed beyond qualitative reference to tens of millions of dollars in potential revenue

Market Context

The platform record adds context: on May 19, the prior daily close recorded a 2.07% change, while co...
Analysis

The platform record adds context: on May 19, the prior daily close recorded a 2.07% change, while comparable announcements produced both gains and declines. The deployment remains subject to later definitive agreements.

Key Figures

Publication date: September 02, 2026 Defense-company ranking: 3 largest Initial deployment: First AME system +2 more
5 metrics
Publication date September 02, 2026 Article publication
Defense-company ranking 3 largest Israel's defense companies
Initial deployment First AME system Installation at partner facilities
Potential aggregate revenue Tens of millions of dollars Potential phased commercial pathway
Partner order backlog Tens of billions of dollars Partner organization description

Historical Context

5 past events · Latest: May 19 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
May 19 Ticker transition Positive +2.1% Strategic focus shifted toward AME and quantum connectivity under a new corporate identity.
May 18 Purchase order Positive -5.8% NYU Langone issued a $580,000 purchase order after evaluating ART100 across more than 30 cases.
May 11 Strategic direction Positive -6.3% Management outlined an AME, quantum connectivity, and medical-business monetization plan.
May 01 AME system order Positive +5.8% A leading Irish technological university ordered an AME system for $596,000.
Apr 30 Development agreement Positive -0.9% QTREX and Qarakal began a joint program targeting cryogenic interconnects for superconducting quantum systems.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Positive announcements produced mixed outcomes, with two aligned gains and three divergences, including declines after a purchase order and strategic-direction update.

Key Terms

additively manufactured electronics, dilution cryostats
2 terms
additively manufactured electronics technical
"focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure"
Additively manufactured electronics are electronic components and circuits created by layer-by-layer printing techniques instead of traditional machining or assembly. Think of building a cake where each layer can contain wiring, sensors or conductive traces so a finished part can combine structure and electronics in one piece. For investors, this can cut production time and part counts, enable custom or lightweight designs, and open new product opportunities or cost savings across manufacturing and supply chains.
dilution cryostats technical
"quantum connectivity solutions for dilution cryostats"
A dilution cryostat is a laboratory machine that creates extremely low temperatures—thousandths of a degree above absolute zero—by using a special mixture of helium isotopes. Think of it as a super-powerful freezer that lets researchers test and run delicate technologies such as quantum processors and ultra-sensitive sensors. For investors, access to or development of these systems signals involvement in advanced, capital-intensive technologies with long development cycles and potential for high strategic value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Ness Ziona, Sept. 02, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure, today announced that one of Israel's three largest defense companies and one of the world's leading aerospace and defense organizations has begun deploying QTREX's AME technology for a joint development program focused on strategic systems operating at the physical limits of precision and performance. The first QTREX AME system is now being installed at the partner's facilities. The agreement includes exclusivity provisions that underscore the strategic importance the partner places on QTREX's technology. It also outlines a potential phased commercial pathway toward broader AME system rollouts, with aggregate revenue for QTREX in the tens of millions of dollars. The partner's identity is not being disclosed at this stage pursuant to contractual confidentiality obligations. 

The joint program is designed to adapt QTREX’s proprietary AME platform to meet the partner’s demanding engineering, performance and reliability requirements. The program establishes a defined collaboration framework encompassing customized R&D, advanced materials and process optimization, with the objective of producing next-generation AME systems built to the partner’s specifications. The initial commercial pathway begins with the immediate system deployment and associated recurring consumables revenue. Subject to the negotiation and execution of definitive agreements between the parties, subsequent phases are structured around the procurement of tailored AME systems, representing a direct and scalable revenue opportunity for QTREX.

The partner is a globally active aerospace and defense organization that develops and deploys mission-critical systems across air, space, sea, land and cyber domains for government and military customers worldwide. Its capabilities span the full lifecycle from research and engineering through integration, qualification, manufacturing and operational deployment, and it has an order backlog measured in the tens of billions of dollars. The organization has also made substantial investments in quantum technologies for defense and civilian applications.

“This program places QTREX inside one of the most advanced aerospace and defense technology environments in the world,” said Dagi Ben-Noon, Chief Executive Officer of QTREX. “Our partner is a global defense technology leader whose innovation is closely watched across the industry. By deploying and tailoring our AME systems to its specific requirements, we believe this program can become a powerful reference point for QTREX and open the door to additional agreements with leading defense, aerospace and quantum customers worldwide.”

About QTREX Quantum

QTREX Quantum Ltd. (Nasdaq: QTEX) is a technology company focused on advanced connectivity and electronics manufacturing solutions for next-generation hardware markets. Following its acquisition of the AME platform, the Company is developing high-density, thermally optimized quantum connectivity solutions for dilution cryostats and advancing AME applications for defense, aerospace, missile, space, and other mission-critical environments. The Company also continues to advance its medical technology portfolio, including respiratory support and blood monitoring platforms, while actively working to monetize certain parts of the medical business.

For more information, please visit: www.q-trex.com

Forward-Looking Statement Disclaimer

This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses discussions, negotiations of and potential entry in to definitive agreements; the installation of QTREX AME system at the defense company’s facility and the expectation to define a phased commercial pathway to broader AME system deployment; the potential revenue that QTREX may derive from the program; QTREX’s proprietary AME platform’s ability to meet the defense company’s demanding engineering, performance and reliability requirements; the establishment of a defined collaboration framework  encompassing customized R&D, advanced materials and process optimization; the production of next-generation AME systems built to the defense company’s specifications; QTREX’s initial potential commercial pathway and associated recurring consumables revenue; that subject to the negotiation and execution of definitive agreements between the parties, subsequent phases are structured around the procurement of tailored AME systems, representing a direct and scalable revenue opportunity for QTREX; the defense company’s capabilities and backlog measurement; the belief that the program can become a powerful reference point for QTREX and open the door to additional agreements with leading defense, aerospace and quantum customers worldwide. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements. More detailed information about the risks and uncertainties affecting the Company is contained under “Risk Factors” in the Company’s annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission.

Company Contact
QTREX Quantum
Email: info@q-trex.com
Phone: +972-9-9664485



QTREX Quantum
Email: info@q-trex.com
Phone: +972-9-9664485

FAQ

What did QTREX Quantum (QTEX) announce about its AME technology deployment?

QTREX Quantum announced that one of Israel’s three largest defense companies, described as a global aerospace and defense leader, has begun deploying QTREX’s AME technology under a joint development program, with the first AME system currently being installed at the partner’s facilities.

How much revenue could the new defense partnership generate for QTREX Quantum (QTEX)?

The agreement outlines a potential phased commercial pathway for broader AME system rollouts, with aggregate revenue for QTREX described as being in the tens of millions of dollars. This figure relates to prospective phases rather than a committed order book.

Who is the defense partner in QTREX Quantum’s (QTEX) new AME program?

The partner is described as one of Israel’s three largest defense companies and a global aerospace and defense organization with mission-critical systems across multiple domains. Its name is not being disclosed at this stage due to contractual confidentiality obligations.

What are the phases of the QTREX Quantum (QTEX) AME commercial pathway with the defense partner?

The initial phase centers on immediate AME system deployment and associated recurring consumables revenue. Subject to negotiation and execution of definitive agreements, subsequent phases are structured around procurement of tailored AME systems, creating a direct and scalable revenue opportunity for QTREX.

What is the focus of the joint development program between QTREX Quantum (QTEX) and the defense company?

The joint program aims to adapt QTREX’s proprietary AME platform to the partner’s demanding engineering, performance and reliability requirements, using customized R&D, advanced materials and process optimization to produce next-generation AME systems built to the partner’s specifications.

How does this AME deployment support QTREX Quantum’s (QTEX) broader strategy?

QTREX focuses on advanced connectivity and electronics manufacturing for next-generation hardware. The company states that deploying and tailoring its AME systems inside a leading aerospace and defense environment can serve as a reference point and potentially open doors to additional defense, aerospace and quantum customers.

What markets beyond defense is QTREX Quantum (QTEX) targeting with its technologies?

QTREX develops high-density quantum connectivity solutions for dilution cryostats and advances AME applications for defense, aerospace, missile, space and other mission-critical environments. It also continues to develop medical technologies such as respiratory support and blood monitoring platforms, while seeking to monetize parts of its medical business.